Analysis of neurotransmitter levels in addiction-related brain regions during synthetic cathinone self-administration in male Sprague-Dawley rats
Synthetic cathinones are used as stimulants of abuse. Different stimulants may induce distinct rates of disease progression, yielding neurochemical changes that may vary across brain regions or neurotransmitter systems.
This research sought to behaviorally and chemically differentiate stages of synthetic cathinone abuse through rodent self-administration and measurement of the neurotransmitter profile in multiple brain regions.
Male rats were trained to self-administer α-PVP, mephedrone (4MMC), or saline. Half of each drug group stopped self-administering after autoshaping; the other half self-administered for another 21 days. Brain tissue from amygdala, hippocampus, hypothalamus, PFC, striatum, and thalamus was profiled with electrochemical detection to assess neurotransmitter levels.
During autoshaping, the majority of infusions were delivered noncontingently. In the self-administration phase, rats responded more for α-PVP and 4MMC than for saline, demonstrating that both synthetic cathinones were reinforcing. Longer durations of exposure elevated 5-HIAA in hypothalamus, PFC, and hippocampus, indicating that learning may produce changes in addiction-related brain regions. Both synthetic cathinones decreased norepinephrine in hippocampus, while α-PVP decreased glutamate in hippocampus and PFC, and 4MMC decreased glutamate in thalamus. Furthermore, α-PVP increased dopaminergic metabolites in striatum, whereas 4MMC decreased serotonin in the amygdala, hippocampus, and PFC. Interestingly, neither synthetic cathinone affected dopamine levels despite their functional effects on the dopaminergic system.
In summary, the neurotransmitter changes observed here suggest that synthetic cathinone use likely produces sequential neurochemical changes during the transition from use to abuse. Consequently, treatment need may differ depending on the progression of synthetic cathinone abuse.
Keywordsα-PVP Mephedrone Neurotransmitter Self-administration
The authors have no conflicts of interest. The authors thank Daniel Barrus, Ricardo Cortes, Tony Landavazo, Timothy Lefever, Nikita Pulley, Shanequa Taylor, Scott Watson, and Jenny Wiley for technical assistance. Research was generously supported by National Institute of Health grants DA039315 and DA012970. The funding source had no other role other than financial support.
- Aarde SM, Creehan KM, Vandewater SA, Dickerson TJ, Taffe MA (2015) In vivo potency and efficacy of the novel cathinone alpha-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats. Psychopharmacology 232:3045–3055. https://doi.org/10.1007/s00213-015-3944-8 CrossRefGoogle Scholar
- Baumann MH, Ayestas MA Jr, Partilla JS, Sink JR, Shulgin AT, Daley PF et al (2012) The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37:1192–1203. https://doi.org/10.1038/npp.2011.304 CrossRefGoogle Scholar
- Cameron K, Kolanos R, Vekariya R, De Felice L, Glennon RA (2013) Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of “bath salts,” produce opposite effects at the human dopamine transporter. Psychopharmacology 227:493–499. https://doi.org/10.1007/s00213-013-2967-2 CrossRefGoogle Scholar
- Chiu K, Lau WM, Lau HT, So KF, Chang RC (2007) Micro-dissection of rat brain for RNA or protein extraction from specific brain region. J Vis Exp 269. https://doi.org/10.3791/269
- Gannon BM, Galindo KI, Mesmin MP, Sulima A, Rice KC, Collins GT (2018) Relative reinforcing effects of second-generation synthetic cathinones: acquisition of self-administration and fixed ratio dose-response curves in rats. Neuropharmacology 134:28–35. https://doi.org/10.1016/j.neuropharm.2017.08.018 CrossRefGoogle Scholar
- Glennon RA, Young R (2016) Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and alpha-pyrrolidinovalerophenone (alpha-PVP). Brain Res Bull 126:111–126. https://doi.org/10.1016/j.brainresbull.2016.04.011 CrossRefGoogle Scholar
- Honkanen A (1999) Modulation of brain dopaminergic neurotransmission in alcohol-preferring rats by alcohol and opioids. Dissertation, University of HelsinkiGoogle Scholar
- Kaddurah-Daouk R, Kristal BS, Weinshilboum RM (2008) Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol 48:653–683. https://doi.org/10.1146/annurev.pharmtox.48.113006.094715 CrossRefGoogle Scholar
- Kaplan KA, Chiu VM, Lukus PA, Zhang X, Siems WF, Schenk JO, Hill HH Jr (2013) Neuronal metabolomics by ion mobility mass spectrometry: cocaine effects on glucose and selected biogenic amine metabolites in the frontal cortex, striatum, and thalamus of the rat. Anal Bioanal Chem 405:1959–1968. https://doi.org/10.1007/s00216-012-6638-7 CrossRefGoogle Scholar
- Kehr J, Ichinose F, Yoshitake S, Goiny M, Sievertsson T, Nyberg F, Yoshitake T (2011) Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats. Br J Pharmacol 164:1949–1958. https://doi.org/10.1111/j.1476-5381.2011.01499.x CrossRefGoogle Scholar
- Koob GF, Le Moal M (2008) Addiction and the brain antireward system. Annu Rev Psychol 59:29–53. https://doi.org/10.1146/annurev.psych.59.103006.093548 CrossRefGoogle Scholar
- Li Y, Yan GY, Zhou JQ, Bu Q, Deng PC, Yang YZ, Lv L, Deng Y, Zhao JX, Shao X, Zhu RM, Huang YN, Zhao YL, Cen XB (2012) (1)H NMR-based metabonomics in brain nucleus accumbens and striatum following repeated cocaine treatment in rats. Neuroscience 218:196–205. https://doi.org/10.1016/j.neuroscience.2012.05.019 CrossRefGoogle Scholar
- Marusich JA, Antonazzo KR, Wiley JL, Blough BE, Partilla JS, Baumann MH (2014) Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology 87:206–213. https://doi.org/10.1016/j.neuropharm.2014.02.016 CrossRefGoogle Scholar
- Motbey CP, Clemens KJ, Apetz N, Winstock AR, Ramsey J, Li KM, Wyatt N, Callaghan PD, Bowen MT, Cornish JL, McGregor IS (2013) High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamine. J Psychopharmacol 27:823–836. https://doi.org/10.1177/0269881113490325 CrossRefGoogle Scholar
- Motbey CP, Karanges E, Li KM, Wilkinson S, Winstock AR, Ramsay J, Hicks C, Kendig MD, Wyatt N, Callaghan PD, McGregor IS (2012) Mephedrone in adolescent rats: residual memory impairment and acute but not lasting 5-HT depletion. PLoS One 7:e45473. https://doi.org/10.1371/journal.pone.0045473 CrossRefGoogle Scholar
- National Research Council (2011) Guide for the care and use of laboratory animals, 8th edn. National Academies Press (US), Washington, D.C.Google Scholar
- NDEWS (2015) National Drug Early Warning System (NDEWS) sentinel community site profile 2015: southeastern Florida. National Drug Early Warning SystemGoogle Scholar
- NDEWS (2016a) Maine sentinel community site drug use patterns and trends, 2016. National Drug Early Warning SystemGoogle Scholar
- NDEWS (2016b) Southeastern Florida (Miami area) sentinel community site drug use patterns and trends, 2016. National Drug Early Warning SystemGoogle Scholar
- NDEWS (2017) Sentinel community site cross-site data presentation: National Forensic Laboratory Information System (NFLIS) 2016 vol cross-site data presentation: NFLIS-19. National Drug Early Warning System Coordinating CenterGoogle Scholar
- Saha K, Partilla JS, Lehner KR, Seddik A, Stockner T, Holy M, Sandtner W, Ecker GF, Sitte HH, Baumann MH (2015) ‘Second-generation’ mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function. Neuropsychopharmacology 40:1321–1331. https://doi.org/10.1038/npp.2014.325 CrossRefGoogle Scholar
- Shortall SE, Macerola AE, Swaby RT, Jayson R, Korsah C, Pillidge KE et al (2013) Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat. Eur Neuropsychopharmacol 23:1085–1095. https://doi.org/10.1016/j.euroneuro.2012.09.005 CrossRefGoogle Scholar
- U.S. Department of Justice DEA (2017) 2017 National Drug Threat Assessment. Springfield, VAGoogle Scholar
- Zaitsu K, Miyawaki I, Bando K, Horie H, Shima N, Katagi M, Tatsuno M, Bamba T, Sato T, Ishii A, Tsuchihashi H, Suzuki K, Fukusaki E (2014) Metabolic profiling of urine and blood plasma in rat models of drug addiction on the basis of morphine, methamphetamine, and cocaine-induced conditioned place preference. Anal Bioanal Chem 406:1339–1354. https://doi.org/10.1007/s00216-013-7234-1 CrossRefGoogle Scholar